Literature DB >> 15740477

Bird's-eye view on gastric cancer research of the past 25 years.

Daiming Fan1, Xueyong Zhang, Xitao Chen, Zhenxian Mou, Jialu Hu, Shaojuan Zhou, Jie Ding, Kaichun Wu.   

Abstract

This paper provides a bird's-eye view of our 25-year research work on gastric cancer, including both exploration of pathogenesis and preclinical or clinical applications of diagnosis and treatment. Although there have been achievements and reasons for applause, there are, nonetheless, more failings and teachings. Some problems that we experienced 25 years ago are still problems we have to face today. We are absolutely not singing the same old tune. Looking back makes us wiser and our way smoother. Although it is a long and arduous way to further study gastric cancer, we are willing to devote ourselves to it.

Entities:  

Mesh:

Year:  2005        PMID: 15740477     DOI: 10.1111/j.1440-1746.2005.03797.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer.

Authors:  T Lin; S Liang; F Meng; Q Han; C Guo; L Sun; Y Chen; Z Liu; Z Yu; H Xie; J Ding; D Fan
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Inhibition of human 67-kDa laminin receptor sensitizes multidrug resistance colon cancer cell line SW480 for apoptosis induction.

Authors:  Chun-Lei Lu; Jian Xu; Hao-Jie Yao; Kun-Lun Luo; Jie-Ming Li; Tao Wu; Guo-Zhong Wu
Journal:  Tumour Biol       Date:  2015-08-21

3.  Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer.

Authors:  Yanxin An; Yi Zhou; Gui Ren; Qifei Tian; Yuanyuan Lu; Hongtao Li; Kai Li; Tao Su; Bin Xu; Shuo Chen; Tao Wang; Xipeng Zhang; Yongzhan Nie; Xin Wang; Qingchuan Zhao
Journal:  Int J Colorectal Dis       Date:  2011-05-15       Impact factor: 2.571

Review 4.  Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Cheng Chi; Yi-Hsin Tseng; Kwang-Huei Lin
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Reversal of multidrug resistance of adriamycin-resistant gastric adenocarcinoma cells through the up-regulation of DARPP-32.

Authors:  Liu Hong; Yunping Zhao; Jin Wang; Ying Han; Wei Guo; Haifeng Jin; Huihong Zhai; Feihu Bai; Xiaoyin Zhang; Taidong Qiao; Zhen Chen; Daiming Fan
Journal:  Dig Dis Sci       Date:  2007-05-11       Impact factor: 3.199

6.  Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis.

Authors:  Xin Wang; Yuanyuan Lu; Jinghua Yang; Yongquan Shi; Mei Lan; Zhenxiong Liu; Huihong Zhai; Daiming Fan
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-29       Impact factor: 4.553

7.  Decreased EGR3 expression is related to poor prognosis in patients with gastric cancer.

Authors:  Fei Liao; Meng-Yao Ji; Lei Shen; Shi Qiu; Xu-feng Guo; Wei-guo Dong
Journal:  J Mol Histol       Date:  2013-03-05       Impact factor: 2.611

8.  MicroRNA‑197 reverses the drug resistance of fluorouracil‑induced SGC7901 cells by targeting mitogen‑activated protein kinase 1.

Authors:  Hai-Lin Xiong; Si-Wei Zhou; Ai-Hua Sun; Ying He; Jun Li; Xia Yuan
Journal:  Mol Med Rep       Date:  2015-07-07       Impact factor: 2.952

9.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.

Authors:  Y An; Z Zhang; Y Shang; X Jiang; J Dong; P Yu; Y Nie; Q Zhao
Journal:  Cell Death Dis       Date:  2015-05-21       Impact factor: 8.469

10.  Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.

Authors:  Lin Zhou; Yulong Shang; Changhao Liu; Jinge Li; Hao Hu; Cong Liang; Yanan Han; Wei Zhang; Jie Liang; Kaichun Wu
Journal:  Int J Cancer       Date:  2014-04-17       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.